I've been thinking a lot lately about how important it is to choose the right clinical trial sites for the success of your trial. Just last week I blogged about the painful process and high costs of closing non-performing or under-performing sites. I recently told a non-industry friend that it can take upwards of 18 months sometimes to usher a clinical site from selection to initiation. He responded, "well that make sense since many clinical trials last several years and it takes a while to give the medication to enough patients to test it out thoroughly." Then I realized he had misunderstood me, I clarified, "Initiation means the doors are open. At initiation, a doctor can start looking for patients. I am telling you that it can take one year or more sometimes just to get a site open for recruitment to start the trial." He was floored and responded, "no wonder we're paying so much for our prescriptions..."
I recently went to an ACRP seminar called 'Why Sites Fail in Study Startup'. The dynamic speaker, Christine Pierre is the President of RxTrials Institute (RxTi) and gave a terrific talk. If you would like to meet her or discuss this topic further, perhaps you would like to attend the Site Solutions Summit in October. I haven't booked my travel yet but I am definitely considering going.
Early bird rates are available now! |
I am excited to see the next-generatiion startup tracker product when it is released. |
So, all of this has led me to develop a new series for the blog focusing on: Site Startup. In addition to my work as a Lead CRA, I have been involved in clinical study site startup for a variety of pharmaceutical companies pretty much without interruption for the past 28 months. Whoa, over 2 years you say? "Surely, Nadia you must have tremendous experience launching study sites for many clinical trials in that time!" Yeah, well uh, regrettably, no. However, in that time I have worked with six disparate clinical operations teams and supported the process of opening a few hundred sites in five different countries (mostly Phase II trial sites).
As a regional monitor at a CRO, I would routinely assist with pre-study site selection visits and administration of feasibility questionnaires but the majority of my work was 85% regional monitoring and site management once sites were open. Since I have moved to an in-house role, I spend a lot more time in the start-up side of things, buried in spreadsheets, trackers, dashboards, and demands from my boss and the board of directors, so I have gleaned some valuable insights. We'll be stepping through several broad topics of site startup in the coming weeks including:
- What are the typical milestones of site startup?
- What is feasibility? How do sponsors choose which clinical trial sites they work with?
- What is an essential document package and a regulatory submission?
- Informed Consent Form templates
- Site Budgets
- Why do contracts take so long? How are they complicated?
- Developing Investigative Site Patient Recruitment Plans
- IRB submissions
- Calculating Investigational Product needs
- Providing study supplies and source documents
- Ensuring sites are adequately trained and prepared to participate
- What correspondence goes in the Trial Master File?
- Metrics, trackers, reports, and dashboards
- Gating tasks...bottlenecks
- Lessons learned, where did the process breakdown?
- How to speed up site startup?
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.